Interleukin-6 has no effect on surfactant or lung function in different lung insults

Experimental Lung Research

Volumn 32, Issue 1-2, 2006, Pages 27-42

  Nakamura, Tomoo ^a   Moyer, Brent Z ^b   Veldhuizen, Ruud A W ^b   Lewis, James F ^b,c  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Acute lung injury; ARDS; Inflammatory cytokines; Interleukin 6; Pulmonary surfactant

Indexed keywords

INTERLEUKIN 6; LUNG SURFACTANT; SODIUM CHLORIDE;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; CECUM; CONTROLLED STUDY; HYPOXIA; IN VIVO STUDY; INTESTINE PERFORATION; LUNG COMPLIANCE; LUNG FUNCTION; LUNG GAS EXCHANGE; LUNG INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; WILD TYPE;

ANIMALS; BRONCHOALVEOLAR LAVAGE; CECUM; DISEASE MODELS, ANIMAL; HYPEROXIA; INTERLEUKIN-6; LUNG; MALE; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; PULMONARY SURFACTANTS; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS;

EID: 33646712586     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1007/s00726-005-0277-7     Document Type: Article

References (30)

1. Frerking I, Gunther A, Seeger W, Pison U: Pulmonary surfactant: functions, abnormalities and therapeutic options. Intensive Care Med. 2001;27:1699-1717.
2. Lewis JF, Jobe AH: Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis. 1993;147:218-233.
3. Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA, Maunder RJ, Crim C, Hyers TM: Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest. 1991;88:1976-1981.
4. Gunther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Walmrath D, Morr H, Seeger W: Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med. 1996;153:176-184.
5. Malloy JL, Veldhuizen RA, McCormack FX, Korfhagen TR, Whitsett JA, Lewis JF: Pulmonary surfactant and inflammation in septic adult mice: role of surfactant protein A. J Appl Physiol. 2002;92:809-816.
6. Arias-Diaz J, Vara E, Garcia C, Balibrea JL: Tumor necrosis factor-alpha-induced inhibition of phosphatidylcholine synthesis by human type 2 pneumocytes is partially mediated by prostaglandins. J Clin Invest. 1994;94:244-250.
7. Pryhuber GS, Bachurski C, Hirsh R, Bacon A, Whitsett JA: Tumor necrosis factor-α decreases surfactant protein B mRNA in m urine lung. Am J Physiol. 1998;270:L714-L721.
8. Salome RG, McCoy DM, Ryan AJ, Mallampalli RK: Effects of intratracheal instillation of TNF-alpha on surfactant metabolism. J Appl Physiol. 2000;88:10-16.
9. Yang L, Lian X, Cowen A, Xu H, Du H, Yan C: Synergy between signal transducer and activator of transcription 3 and retinoic acid receptor-alpha in regulation of the surfactant protein B gene in the lung. Mol Endocrinol. 2004;18:1520-1532.
10. Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, Umberger R, Leeper K Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest. 1995;107:1062-1073.
11. Schutte H, Lohmeyer J, Rosseau S, Ziegler S, Siebert C, Kielisch H, Pralle H, Grimminger F, Morr H, Seeger W: Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J. 1996;9:1858-1867.
12. Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The acute respiratory distress syndrome network. N Engl J Med. 2000;342:1301-1308.
13. Ward NS, Waxman AB, Homer RJ, Mantell LL, Einarsson O, Du Y, Elias JA: Interleukin-6-induced protection in hyperoxic acute lung injury. Am J Respir Cell Mol Biol. 2000;22:535-542.
14. Andrejko KM, Chen J, Deutschman CS: Intrahepatic STAT-3 activation and acute phase gene expression predict outcome after CLP sepsis in the rat. Am J Physiol. 1998;275(6 Pt 1):G1423-G1429.
15. Veldhuizen RAW, Tremblay LN, Govindarajan A, Rozendaal BAWM, Haagsman HP, Slutsky AS: Pulmonary surfactant is altered during mechanical ventilation of isolated rat lung. Crit Care Med. 2000;28:2545-2551.
16. Veldhuizen RA, Welk B, Harbottle R, Hearn S, Nag K, Petersen N, Possmayer F: Mechanical ventilation of isolated rat lungs changes the structure and biophysical properties of surfactant. J Appl Physiol. 2002;92:1169-1175.
17. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911-917.
18. Duck-Chong CG: A rapid sensitive method for determining phospholipid phosphorus involving digestion with magnesium nitrate. Lipids. 1979;14:492-497.
19. Brackenbury AM, Malloy JL, McCaig LA, Yao LJ, Veldhuizen RA, Lewis JF: Evaluation of alveolar surfactant aggregates in vitro and in vivo. Eur Respir J. 2002;19:41-46.
20. Veldhuizen RAW, Slutsky AS, Joseph M, McCaig L: Effects of mechanical ventilation of isolated mouse lungs on pulmonary surfactant and inflammatory cytokines. Eur Respir J. 2001;17:488-494.
21. Bailey TC, Martin EL, Zhao L, Veldhuizen RA: High oxygen concentrations predispose mouse lungs to the deleterious effects of high stretch ventilation. J Appl Physiol. 2003;94:975-982.
22. Ikegami M, Whitsett JA, Chroneos ZC, Ross GF, Reed JA, Bachurski CJ, Jobe AH: IL-4 increases surfactant and regulates metabolism in vivo. Am J Physiol Lung Cell Mol Physiol. 2000;278:L75-L80.
23. Dreyfuss D, Saumon G: Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med. 1998;157:294-323.
24. Raymondos K, Leuwer M, Haslam PL, Vangerow B, Ensink M, Tschorn H, Schurmann W, Husstedt H, Rueckoldt H, Piepenbrock S: Compositional, structural, and functional alterations in pulmonary surfactant in surgical patients after the early onset of systemic inflammatory response syndrome or sepsis. Crit Care Med. 1999;27:82-89.
25. Holm BA, Notter RH, Siegle J, Matalon S: Pulmonary physiological and surfactant changes during injury and recovery from hyperoxia. J Appl Physiol. 1985;59:1402-1409.
26. Balaan MR, Bowman L, Dedhia HV, Miles PR: Hyperoxia-induced alterations of rat alveolar lavage composition and properties. Exp Lung Res. 1995;21:141-156.
27. Stephanou A, Isenberg DA, Akira S, Kishimoto T, Latchman DS: The nuclear factor interleukin-6 (NF-IL6) and signal transducer and activator of transcription-3 (STAT-3) signalling pathways co-operate to mediate the activation of the hsp90beta gene by interleukin-5 but have opposite effects on its inducibility by heat shock. Biochem J. 1998;15 (Pt 1):189-195.
28. Henttinen T, Levy DE, Silvennoinen O, Hurme M: Activation of the signal transducer and transcription (STAT) signaling pathway in a primary T cell response. Critical role for IL-6.J Immunol. 1995;155:4582-4587.
29. Pison U, Max M, Neuendank A, Weissbach S, Pietschmann S: Host defence capacities of pulmonary surfactant: evidence for 'non-surfactant' functions of the surfactant system. Eur J Clin Invest. 1994;24:586-599.
30. Wright JR: Immunomodulatory functions of surfactant. Physiol Rev. 1997;77:931-962.